FindTrial
Sign In

The effect of morphine added to ropivacaine in ultrasound-guided anterior serratus plane block for postoperative analgesia following breast cancer surgery

The effect of morphine added to ropivacaine in ultrasound-guided anterior serratus plane block for postoperative analgesia following breast cancer surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030384
Enrollment
Unknown
Registered
2020-03-01
Start date
2020-03-03
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

control group:20mL 0.375% ropivacaine
experimental group:20mL 0.375% ropivacaine and 2mg morphine

Sponsors

Yantai Yuhuangding Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 55 Years

Inclusion criteria

Inclusion criteria: 60 patients with radical mastectomy , ASA I-II, aged 30 to 60 years.

Exclusion criteria

Exclusion criteria: Severe liver and kidney disease; History of anaphylaxis; Puncture site infection; Coagulant dysfunction.

Design outcomes

Primary

MeasureTime frame
resting VAS pain score;The time, type and dosage of analgesic drugs were first appended for 24h after surgery;Adverse reactions;Ramsay score;—

Countries

China

Contacts

Public ContactJiang Aihua

Yantai Yuhuangding Hospital

jahzy@126.com+86 13863880266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026